射频消融治疗肝脏高危部位肿瘤的并发症及其防治策略

宋莉; 邹英华

doi:10.3969/j.issn.1001-5256.2017.04.009

射频消融治疗肝脏高危部位肿瘤的并发症及其防治策略

DOI: 10.3969/j.issn.1001-5256.2017.04.009

宋莉,
邹英华

北京大学第一医院介入血管外科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2391
- HTML全文浏览量: 12
- PDF下载量: 477
- 被引次数: 0
出版历程
- 出版日期: 2017-04-20

Prevention and treatment of complications after radiofrequency ablation for hepatic tumors in high-risk locations

Department of Interventional and Vascular Surgery, Peking University First Hospital

摘要

摘要:
经皮射频消融(RFA)已广泛应用于肝脏恶性肿瘤的治疗,疗效肯定。目前,RFA的术后并发症倍受关注,其发生风险与肿瘤的位置密切相关。肝脏高危部位恶性肿瘤行RFA治疗的难度大、风险高,对于临床医师是个挑战。回顾了肝脏高危部位肿瘤RFA治疗的并发症,并对其防治策略做了整理与分析。
- 肝肿瘤 /
- 导管消融术 /
- 手术后并发症 /
- 预防
Abstract:
Percutaneous radiofrequency ablation ( RFA) has been widely used in the treatment of malignant hepatic tumors and has achieved satisfactory effects. Complications after RFA have been taken seriously and the risk of the development of complications is closely associated with tumor location. It is a great challenge for physicians to perform RFA for hepatic tumors in high-risk locations due to related difficulties and risks. This article reviews the complications after RFA for hepatic tumors in high-risk locations and analyzes related control strategies.
- liver neoplasms /
- catheter ablation /
- postoperative complications /
- prevention

HTML全文

参考文献(27)

[1]SOLBIATI L, AHMED M, COVA L, et al.Small liver colorectal metastases treated with percutaneous radiofrequency ablation:local response rate and long-term survival with up to 10-year followup[J].Radiology, 2012, 265 (3) :958-968.

[2]GERVAIS DA, ARELLANO RS, MUELLER PR.Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver:indications, outcomes, and role in patient management[J].AJR Am J Roentgenol, 2006, 187 (3) :746-750.

[3]ZHANG W, JIANG L, YAN L, et al.Radiofrequency ablation for HCC patients with multifocal tumours meeting the Milan criteria:a single-centreexperience[J].Dig Liver Dis, 2016, 48 (12) :1485-1491.

[4]van TILBORG AA, SCHEFFER HJ, de JONG MC, et al.MWA versus RFA for perivascular and peribiliary CRLM:a retrospective patientand lesion-based analysis of two historical cohorts[J].Cardiovasc Intervent Radiol, 2016, 39 (10) :1438-1446.

[5]XU Q, KOBAYASHI S, YE X, et al.Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma:a meta-analysis of 16103 patients[J].Sci Rep, 2014, 4 (Suppl2) :7252.

[6]FENG Q, CHI Y, LIU Y, et al.Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma:a meta-analysis of 23 studies[J].J Cancer Res Clin Oncol, 2015, 141 (1) :1-9.

[7]TANG T, FENG X, YAN J, et al.Predictive value of indocyanine green retention rate with respect to complications of radiofrequency ablation in 878 patients with hepatocellular carcinoma[J].Int J Hyperthermia, 2014, 30 (6) :402-407.

[8]Chinese Society of Liver Cancer and Clinical Oncology, Chinese Anti-Cancer Association;Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association.Expert consensus on local ablation therapy for liver cancer[J].Tumor, 2011, 31 (5) :385-388. (in Chinese) 中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组.肝癌局部消融治疗规范的专家共识[J].肿瘤, 2011, 31 (5) :385-388.

[9]MICHALIS K, FOTIOS L, KATERINA K, et al.Percutaneous radiofrequency ablation for malignant liver tumours in challenging locations[J].J Med Imaging Radiat Oncol, 2012, 56 (1) :48-54.

[10]THAMTORAWAT S, ROJWATCHARAPIBARN S, TONGDEE T, et al.The outcome of radiofrequency ablation of metastatic liver tumors[J].J Med Assoc Thai, 2016, 99 (4) :424-432.

[11]YANG W, YAN K, WU GX, et al.Radiofrequency ablation of hepatocellular carcinoma in difficult locations:strategies and longterm outcomes[J].World J Gastroenterol, 2015, 21 (5) :1554-1566.

[12]Cancer Therapy Evaluation Program.Common terminology criteria for adverse events, version 4.03:the national cancer institute common toxicity criteria[S/OL].http://evs.nci.nih.gov/ftp1/CTCAE/About.html.

[13]CHANG IS, KIM YJ, PARK SW, et al.Delayed hepatic rupture after radiofrequency ablation for colorectal hepatic metastasis:management with transcatheter arterial embolization[J].Ann Surg Treat Res, 2014, 87 (1) :41-43.

[14]FONSECA AZ, SANTIN S, GOMES LG, et al.Complications of radiofrequency ablation of hepatic tumors:frequency and risk factors[J].World J Hepatol, 2014, 6 (3) :107-113.

[15]ABE T, AMANO H, TAKECHI H, et al.Late-onset diaphragmatic hernia after percutaneous radiofrequency ablation of hepatocellular carcinoma:a case study[J].Surg Case Rep, 2016, 2 (1) :25.

[16]NAKAMURA T, MASUDA K, THETHI RS, et al.Successful surgical rescue of delayed onset diaphragmatic hernia following radiofrequency ablation for hepatocellular carcinoma[J].Ulus Travma Acil Cerrahi Derg, 2014, 20 (4) :295-299.

[17]MOGENSEN MF, EDLING P, RAADE TB, et al.Hepato-pericardial fistula caused by radiofrequency ablation of colorectal liver metastases[J].Ugeskr Laeger, 2015, 177 (14) :v09140481.

[18]LIU CH, YU CY, CHANG WC, et al.Computed tomographicguided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location:Evaluation of safety and technical efficacy[J].J Chin Med Assoc, 2016, 79 (2) :93-100.

[19]FUJIWARA H, ARAI Y, ISHII H, et al.Computed tomographyguided radiofrequency ablation for sub-diaphragm hepatocellular carcinoma:safety and efficacy of inducing an artificial pneumothorax[J].Acta Med Okayama, 2016, 70 (3) :189-195.

[20]SUN WB, WANG ZY, ZHANG YF, et al.Percutaneous radiofrequency ablation therapy with left single lung ventilation for liver carcinoma in the hepatic dome[J].Chin J Surg, 2007, 45 (17) :1179-1181. (in Chinese) 孙文兵, 王振元, 张延峰, 等.单肺通气条件下经皮经肝射频消融治疗肝顶部肝癌[J].中华外科杂志, 2007, 45 (17) :1179-1181.

[21]DONG IC, MIN WL, HYUNCHUL R, et al.Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations[J].Korean J Radiol, 2013, 14 (2) :240-247.

[22]LYU TS, ZOU YH, WANG J, et al.Expert consensus on the norms of local ablation therapy for hepatocellular carcinoma[J].Clin J Hepatol, 2016, 32 (1) :49-55. (in Chinese) 吕天石, 邹英华, 王健, 等.经肝动脉化疗栓塞术联合射频消融治疗原发性肝癌的现状[J].临床肝胆病杂志, 2016, 32 (1) :49-55.

[23]HYUN D, CHO SK, SHIN SW, et al.Treatment of small hepatocellular carcinoma (≤2 cm) in the caudate lobe with sequential transcatheter arterial chemoembolization and radiofrequency ablation[J].Cardiovasc Intervent Radiol, 2016, 39 (7) :1015-1022.

[24]STIPPEL DL, BANGARD C, KASPER HU, et al.Experimental bile duct protection by intraductal cooling during radiofrequency ablation[J].Br J Surg, 2005, 92 (7) :849-855.

[25]IMAI Y, HIROOKA M, OCHI H, et al.A case of hepatocellular carcinoma treated by radiofrequency ablation confirming the adjacent major bile duct under hybrid contrast mode through a biliary drainage catheter[J].Clin J Gastroenterol, 2015, 8 (5) :318-322.

[26]de BAERE T, BESSOUD B, DROMAIN C, et al.Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion[J].AJR Am J Roentgenol, 2002, 178 (1) :53-59.

[27]ERCE C, PARKS RW.Interstitial ablative techniques for hepatic tumours[J].Br J Surg, 2003, 90 (3) :272-289.

施引文献

资源附件(0)

访问统计